Finance

Lists
Q2 2026 earnings
See details
GXI:ETR
Gerresheimer AG
€27.56
-0.58%
(-0.16) 1D
Oct 2, 5:17:34 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GXI...
Open
€27.52
High
€28.04
Low
€27.10
Mkt. cap
951.92M
Avg. vol.
144.98K
Volume
35.07K
52-wk high
€38.32
52-wk low
€14.83
EPS
-€9.27
Shares outstanding
34.54M
No. of employees
14K
Open
€27.52
High
€28.04
Low
€27.10
Mkt. cap
951.92M
Avg. vol.
144.98K
Volume
35.07K
52-wk high
€38.32
52-wk low
€14.83
EPS
-€9.27
Shares outstanding
34.54M
No. of employees
14K
News stories
From web sources and news partners
Profile
Gerresheimer AG is a German manufacturer of primary packaging products for medication and drug delivery devices made of special-purpose glass and plastics with headquarters in Düsseldorf for the pharmaceutical and cosmetics industries. The company has production operations in Europe, the Americas and Asia. Wikipedia
About Gerresheimer AG
CEODietmar Siemssen
Employees13.5K
Founded1864
HeadquartersDüsseldorf, North Rhine-Westphalia, Germany
SectorHealth care
Websitegerresheimer.com
Awaiting results...
Call Time: Wed, Sep 30, 3:00 PM
Fiscal period
Q2 2026
EPS / Est. (EUR)
- / €0.90
Revenue / Est. (EUR)
- / 600.44M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Feb 2025
May 2025
Aug 2025
Nov 2025
Revenue
520.05M
600.66M
560.68M
639.49M
Cost of goods sold
393.30M
442.82M
421.79M
514.68M
Cost of revenue
393.30M
442.82M
421.79M
514.68M
Research and development expenses
6.12M
3.16M
5.56M
7.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
103.17M
105.31M
100.98M
129.19M
Operating expense
111.63M
107.16M
131.51M
93.14M
Total operating expenses
504.94M
549.99M
553.30M
607.81M
Operating income
15.12M
50.67M
7.38M
31.68M
Other non operating income
824.00K
739.00K
337.00K
-51.51M
EBT including unusual items
-25.32M
28.78M
-15.01M
-318.58M
EBT excluding unusual items
-25.32M
28.78M
-15.01M
-31.14M
Income tax expense
-7.83M
11.16M
-2.74M
-11.99M
Effective tax rate
30.93%
38.77%
18.26%
3.76%
Other operating expenses
2.35M
-1.30M
24.96M
-43.39M
Net income
-18.01M
17.02M
-12.70M
-306.62M
Net profit margin
-3.46%
2.83%
-2.27%
-47.95%
Earnings per share
0.46
0.90
0.69
-4.44
Interest and investment income
1.27M
947.00K
627.00K
820.00K
Interest expense
-42.53M
-23.58M
-23.36M
-8.30M
Net interest expenses
-41.26M
-22.63M
-22.73M
-7.48M
Depreciation and amortization charges
-
-
-
-
EBITDA
82.31M
117.72M
74.08M
84.14M
Gain or loss from assets sale
164.00K
-41.00K
-49.00K
12.94M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps